Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-039914
Filing Date
2025-08-12
Accepted
2025-08-12 16:32:29
Documents
111
Period of Report
2025-06-28

Document Format Files

Seq Description Document Type Size
1 10-Q jan-20250628.htm   iXBRL 10-Q 1872253
2 EX-31.1 alt5-20250628xexx311.htm EX-31.1 9653
3 EX-31.2 alt5-20250628xexx312.htm EX-31.2 9615
4 EX-32.1 alt5-20250628xexx321.htm EX-32.1 3776
5 EX-32.2 alt5-20250628xexx322.htm EX-32.2 3729
  Complete submission text file 0001628280-25-039914.txt   11317479

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jan-20250628.xsd EX-101.SCH 91796
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jan-20250628_cal.xml EX-101.CAL 103525
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jan-20250628_def.xml EX-101.DEF 582454
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jan-20250628_lab.xml EX-101.LAB 930171
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jan-20250628_pre.xml EX-101.PRE 795412
114 EXTRACTED XBRL INSTANCE DOCUMENT jan-20250628_htm.xml XML 1593209
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Filer) CIK: 0000862861 (see all company filings)

EIN.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19621 | Film No.: 251207280
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)